tiprankstipranks
Advertisement
Advertisement

MTVA Stock Latest News

MetaVia (MTVA): Buy Rating Reiterated as DA-1726 Nears Key 4Q26 Data; $20 Price Target Reaffirmed
RatingsMetaVia (MTVA): Buy Rating Reiterated as DA-1726 Nears Key 4Q26 Data; $20 Price Target Reaffirmed
17d ago
MTVA
MetaVia Advances DA-1726 and Vanoglipel in Q2 Update
PremiumCompany Announcements
MetaVia Advances DA-1726 and Vanoglipel in Q2 Update
20d ago
8K
MTVA
Analyst Maintains Buy on MetaVia, Keeps $8 Price Target as DA-1726 Next-Gen Obesity Data Advances
PremiumRatings
Analyst Maintains Buy on MetaVia, Keeps $8 Price Target as DA-1726 Next-Gen Obesity Data Advances
2M ago
MTVA
Analyst Reaffirms Buy on MTVA as DA-1726 Data De-Risk Obesity and MASH Opportunity; Price Target Maintained at $20
PremiumRatings
Analyst Reaffirms Buy on MTVA as DA-1726 Data De-Risk Obesity and MASH Opportunity; Price Target Maintained at $20
2M ago
MTVA
MetaVia Advances DA-1726 Obesity Trial to Top Doses
PremiumCompany Announcements
MetaVia Advances DA-1726 Obesity Trial to Top Doses
2M ago
8K
MTVA
MetaVia announces completion of dose titration in Phase 1 study of DA-1726
PremiumThe FlyMetaVia announces completion of dose titration in Phase 1 study of DA-1726
2M ago
MTVA
MetaVia Announces $4 Million At-The-Market Stock Offering
Premium
Company Announcements
MetaVia Announces $4 Million At-The-Market Stock Offering
2M ago
8K
MTVA
MetaVia: Buy Rating Reiterated as Synergistic Cardiometabolic Pipeline Supports Unchanged $8 Price Target
Premium
Ratings
MetaVia: Buy Rating Reiterated as Synergistic Cardiometabolic Pipeline Supports Unchanged $8 Price Target
3M ago
MTVA
MetaVia Shareholders Approve Equity Plan and Reverse Split
PremiumCompany Announcements
MetaVia Shareholders Approve Equity Plan and Reverse Split
3M ago
8K
MTVA
MetaVia highlights obesity and metabolic pipeline advancements
PremiumCompany Announcements
MetaVia highlights obesity and metabolic pipeline advancements
3M ago
8K
MTVA
MetaVia presents data at ADA supporting DA-1726, vanoglipel
PremiumThe Fly
MetaVia presents data at ADA supporting DA-1726, vanoglipel
3M ago
MTVA
Fein Reiterates Buy on MetaVia as New Phase 1 Liver Data De-Risk DA-1726 and Support Unchanged $20 Price Target
PremiumRatings
Fein Reiterates Buy on MetaVia as New Phase 1 Liver Data De-Risk DA-1726 and Support Unchanged $20 Price Target
3M ago
MTVA
MetaVia’s DA-1726 shows efficacy in obesity and MASH presentations
PremiumThe FlyMetaVia’s DA-1726 shows efficacy in obesity and MASH presentations
3M ago
MTVA
MetaVia highlights promising Phase 1 obesity drug data
Premium
Company Announcements
MetaVia highlights promising Phase 1 obesity drug data
3M ago
8K
MTVA
3 Penny Stocks to Watch Now, 5/21/26
Premium
Market News
3 Penny Stocks to Watch Now, 5/21/26
3M ago
HCWB
MTVA
Analyst Reiterates Buy on MetaVia, Maintains $8 Price Target Amid Promising Metabolic Pipeline and Upcoming Data Catalysts
PremiumRatings
Analyst Reiterates Buy on MetaVia, Maintains $8 Price Target Amid Promising Metabolic Pipeline and Upcoming Data Catalysts
3M ago
MTVA
Fein Reiterates Buy on MetaVia, Keeps DA-1726-Driven Price Target Unchanged at $20
PremiumRatings
Fein Reiterates Buy on MetaVia, Keeps DA-1726-Driven Price Target Unchanged at $20
3M ago
MTVA
MetaVia Showcases Key Cardiometabolic Data at ADA 2026
PremiumCompany Announcements
MetaVia Showcases Key Cardiometabolic Data at ADA 2026
3M ago
8K
MTVA
MetaVia Highlights Strong DA-1726 Phase 1 Weight-Loss Data
PremiumCompany Announcements
MetaVia Highlights Strong DA-1726 Phase 1 Weight-Loss Data
3M ago
8K
MTVA
MetaVia to Present New DA-1726 Obesity Data at EASL
PremiumCompany AnnouncementsMetaVia to Present New DA-1726 Obesity Data at EASL
4M ago
8K
MTVA
MetaVia Advances DA-1726 Obesity Trial With First Patient
Premium
Company Announcements
MetaVia Advances DA-1726 Obesity Trial With First Patient
5M ago
8K
MTVA
MetaVia says first patient dosed in Part 3 of Phase 1 trial of DA-1726
Premium
The Fly
MetaVia says first patient dosed in Part 3 of Phase 1 trial of DA-1726
5M ago
MTVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >